Published in Biotech Business Week, January 10th, 2005
Under the terms of the agreement, Chromos and Pfizer will collaborate to engineer a variety of cell lines specific for the expression of a Pfizer protein using the ACE System. Upon completion of the Pfizer-funded collaboration, Pfizer will evaluate the performance of the engineered cell lines. The financial details of the agreement were not disclosed.
"We are extremely pleased to be working with Pfizer, the world's largest...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.